Published in Pediatr Dermatol on March 01, 1992
Childhood granulomatous periorificial dermatitis. Ann Dermatol (2011) 0.91
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life. Am Health Drug Benefits (2013) 0.88
Case for diagnosis: childhood granulomatous periorificial dermatitis. An Bras Dermatol (2013) 0.75
Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell (1991) 3.49
Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol (2001) 1.66
The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell (1992) 1.51
Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis. J Pediatr (1992) 1.46
Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature. J Am Acad Dermatol (1998) 1.44
Drug administration to the pregnant or lactating woman: a reference guide for dermatologists. J Am Acad Dermatol (1990) 1.43
Juvenile dermatomyositis presenting with rash alone. Pediatrics (1997) 1.42
Response of deep tufted angioma to interferon alfa. J Am Acad Dermatol (1995) 1.39
Pseudoporphyria cutanea tarda: two case reports on children receiving peritoneal dialysis and erythropoietin therapy. J Pediatr (1992) 1.38
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol (1999) 1.34
Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol (1998) 1.28
Localized facial flushing in infancy. Auriculotemporal nerve (Frey) syndrome. Arch Dermatol (1997) 1.22
Cutaneous changes associated with inflammatory bowel disease. Pediatr Dermatol (1986) 1.16
A novel KIT mutation results in piebaldism with progressive depigmentation. J Am Acad Dermatol (2001) 1.13
Rat bite fever in a pet lover. J Am Acad Dermatol (1998) 1.09
Aquagenic palmoplantar keratoderma. J Am Acad Dermatol (2001) 1.09
Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. J Invest Dermatol (1991) 1.06
Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation. Glycobiology (2001) 1.02
Primary generalized and localized hypertrichosis in children. Arch Dermatol (2001) 1.01
Full-thickness surgical excision for the treatment of inflammatory linear verrucous epidermal nevus. Ann Plast Surg (2001) 0.99
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Localization of the alpha 3 (V) chain of type V collagen in human skin. J Invest Dermatol (1987) 0.97
Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminase. J Biol Chem (1997) 0.96
Pustulosis palmaris et plantaris: its association with chronic recurrent multifocal osteomyelitis. J Am Acad Dermatol (1985) 0.94
Knuckle pads in children. Am J Dis Child (1986) 0.94
A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol (2007) 0.93
Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol (1988) 0.92
Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med (2001) 0.92
What syndrome is this? Ankyloblepharon-ectodermal defects--cleft lip and palate (Hay-Wells) syndrome. Pediatr Dermatol (1998) 0.92
Hodgkin's disease manifesting as prurigo nodularis. Pediatr Dermatol (1990) 0.91
Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. J Clin Invest (1994) 0.91
What syndrome is this? CHIME syndrome. Pediatr Dermatol (2001) 0.90
Dermolytic (dystrophic) epidermolysis bullosa inversa. Arch Dermatol (1988) 0.90
Guidelines of care for neurofibromatosis type 1. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol (1997) 0.90
Cracks in the foundation: keratin filaments and genetic disease. Trends Cell Biol (1994) 0.90
Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr (1993) 0.87
Sarcoidosis in children: differentiation from juvenile rheumatoid arthritis. Pediatr Dermatol (1987) 0.87
Inhibition of integrin-linked kinase/protein kinase B/Akt signaling: mechanism for ganglioside-induced apoptosis. J Biol Chem (2001) 0.86
Hemorrhagic pityriasis rosea: an unusual variant. Pediatrics (1982) 0.86
Carbohydrate-carbohydrate binding of ganglioside to integrin alpha(5) modulates alpha(5)beta(1) function. J Biol Chem (2000) 0.85
Itraconazole pulse therapy for dermatophyte onychomycosis in children. Arch Pediatr Adolesc Med (2000) 0.85
Congenital rhabdoid sarcoma with cutaneous metastases. J Am Acad Dermatol (1990) 0.84
Restoration of open reading frame resulting from skipping of an exon with an internal deletion in the COL7A1 gene. Lab Invest (1998) 0.84
Prenatal diagnosis for recessive dystrophic epidermolysis bullosa in 10 families by mutation and haplotype analysis in the type VII collagen gene (COL7A1). Mol Med (1996) 0.83
Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1986) 0.83
Chemiluminescence detection of gangliosides by thin-layer chromatography. J Lipid Res (1995) 0.83
LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels. Lab Invest (1998) 0.83
Cutaneous sarcoidosis associated with sarcoidosis of the upper airway. Arch Dermatol (1983) 0.83
Vitamin D deficiency and rickets in children and adolescents with ichthyosiform erythroderma in type IV and V skin. Br J Dermatol (2012) 0.83
Clinical pearl: use of self-adhesive, compressive wraps in the treatment of limb hemangiomas. J Am Acad Dermatol (1995) 0.83
Severe infantile epidermolysis bullosa simplex. Dowling-Meara type. Arch Dermatol (1986) 0.83
Elastase and neutral cathepsin production by human fibroblasts: effect of culture conditions on synthesis and secretion. J Invest Dermatol (1986) 0.82
In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model. J Invest Dermatol (1999) 0.82
Squaric acid immunotherapy for warts in children. J Am Acad Dermatol (2000) 0.82
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. Br J Dermatol (2007) 0.81
Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res (1997) 0.81
Hedgehog hives. Arch Dermatol (1999) 0.81
Ganglioside modulates ligand binding to the epidermal growth factor receptor. J Invest Dermatol (2001) 0.81
A disease resembling junctional epidermolysis bullosa in a toy poodle. Am J Dermatopathol (1988) 0.81
Langerhans cell histiocytosis and dermatophytosis. J Am Acad Dermatol (1993) 0.81
Histology of lipoid proteinosis. JAMA (1994) 0.80
Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol (1998) 0.80
Familial multiple cafe au lait spots. Arch Dermatol (1994) 0.80
Integrin alpha 5 beta 1 expression is required for inhibition of keratinocyte migration by ganglioside GT1b. Exp Cell Res (1998) 0.80
What syndrome is this? Congenital Kasabach-Merritt syndrome. Pediatr Dermatol (1994) 0.79
Chediak-Higashi syndrome in a black child. Pediatr Dermatol (1992) 0.78
Cutaneous Fusarium infection in an adolescent with acute leukemia. Pediatr Dermatol (1992) 0.78
The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States. Arch Dermatol (1986) 0.77
Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol (1999) 0.76
Inhibitory action of ganglioside GM3 on murine neuroblastoma cell proliferation: modulating effect of fetal calf serum. Anticancer Res (1995) 0.76
Expanding our concepts of mosaic disorders of skin. Arch Dermatol (2001) 0.76
Dermatologic uses of methotrexate in children: indications and guidelines. Pediatr Dermatol (1985) 0.76
Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome. J Am Acad Dermatol (1998) 0.76
Cimetidine for the treatment of warts. West J Med (1996) 0.76
Two cases of incontinentia pigmenti simulating child abuse. Pediatrics (1997) 0.75
Raised limb bands developing in infancy. Br J Dermatol (2003) 0.75
The diagnosis and management of acne. Pediatr Ann (2000) 0.75
Pigmentary patterning as a clinical clue of genetic mosaicism. Arch Dermatol (1996) 0.75
Ataxia-telangiectasia. J Am Acad Dermatol (1995) 0.75
Inefficacy of oral cimetidine for nonatopic children with molluscum contagiosum. Pediatr Dermatol (1998) 0.75
Ongoing blistering in a boy with congenital erosive and vesicular dermatosis healing with reticulated supple scarring. J Am Acad Dermatol (2001) 0.75
Proceedings of the Society for Pediatric Dermatology meeting, June 29-July 1, 1995, Vancouver, British Columbia, Canada. Pediatr Dermatol (1995) 0.75
Meclofenamate for psoriasis. Arch Dermatol (1984) 0.75
Plantar erythema nodosum: cases in two children. Arch Dermatol (1993) 0.75
A pruritic eruption with reticular pigmentation. Prurigo pigmentosa. Arch Dermatol (1993) 0.75
Atrophie blanche with onset in childhood. J Pediatr (1993) 0.75
Proceedings of the Society for Pediatric Dermatology meeting. Hilton Head, South Carolina, June 22-25, 1994. Pediatr Dermatol (1994) 0.75
Pedal hemangiomas in Turner syndrome. J Pediatr (1983) 0.75
A colorimetric bead-binding assay for detection of intermolecular interactions. Exp Dermatol (2002) 0.75
Ocular and dermatologic manifestation of neurocutaneous syndromes. Dermatol Clin (1992) 0.75
Epidermal nevus syndrome. Neurol Clin (1987) 0.75
Stump the experts. Cutaneous bronchogenic cyst. Dermatol Surg (1995) 0.75
Metabolic disorders characterized by angiokeratomas and neurologic dysfunction. Neurol Clin (1987) 0.75
Extensive ichthyosiform sarcoidosis in a patient with juvenile rheumatoid arthritis. Arch Dermatol (1985) 0.75
Multiple cutaneous nodules in a newborn. Pediatr Dermatol (1995) 0.75
Ataxia-telangiectasia. Neurol Clin (1987) 0.75
Dermatologic clues to inherited disease. Pediatr Clin North Am (2000) 0.75
Melanoma in prepubertal children. Int Surg (1994) 0.75
Common skin problems during the first year of life. Pediatr Clin North Am (1994) 0.75
Primary cutaneous T-cell lymphoma in a child. Pediatr Dermatol (1984) 0.75